SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001213900-21-007904
Filing Date
2021-02-10
Accepted
2021-02-10 06:08:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 FWP ea135100-fwp_enlivex.htm FWP 11929
  Complete submission text file 0001213900-21-007904.txt   13954
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filed by) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-232009 | Film No.: 21609142
SIC: 2834 Pharmaceutical Preparations